Top Tweets for #METInhibitor

almost 2 years ago

Dr @b_doleschal & colleagues present a case of a young pt w/ MET-amplified #hpbcsm w/ ⬆️ #ORR on tepotinib, a novel highly selective #METinhibitor after progression on 1st-line treatment. More prospective trials are needed for these rare cases. #GIonc https://t.co/30qYTjVdnB

OncJournal's tweet photo. Dr @b_doleschal & colleagues present a case of a young pt w/ MET-amplified #hpbcsm w/ ⬆️ #ORR on tepotinib, a novel highly selective #METinhibitor after progression on 1st-line treatment. More prospective trials are needed for these rare cases. #GIonc
https://t.co/30qYTjVdnB https://t.co/h9HX1WiEZu

Targeted Oncology @TargetedOnc

almost 6 years ago

TPX-0022, a #METinhibitor, investigated in the phase 1 dose-escalation study, SHIELD-1, was shown to be safe and well tolerated in patients with advanced solid tumors harboring MET alterations. https://t.co/2EfjXTQDuL #solidtumors

1stOncology @1stOncology

over 6 years ago

#FoundationMedicine Receives FDA Approval for #FoundationOneCDx as the #CompanionDiagnostic for #Tabrecta™ (#Capmatinib), the Only #FDA-Approved #METInhibitor for Patients With Metastatic #NonSmallCellLungCancer With #METex14 https://t.co/LceIX6Pt54

Top Tweets for #METInhibitor

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users